November 8, 2022 By Jim Hammerand What’s next for Medtronic RDN after Symplicity Spyral trial ‘surprise’?
July 18, 2022 By Jim Hammerand What Fresenius learned about COVID, kidneys and dialysis in the pandemic
June 22, 2022 By Jim Hammerand How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
February 22, 2022 By Sean Whooley Hugo feedback is positive as Medtronic looks to scale production of surgical robot
January 10, 2022 By Sean Whooley Hugo, renal denervation and diabetes businesses to drive growth despite setbacks, Medtronic CEO says
August 25, 2021 By Jim Hammerand Medtronic CEO Geoff Martha touts progress on renal denervation and Hugo robotics
August 19, 2021 By Danielle Kirsh Spectra Laboratories opens renal lab services facility in Mississippi
